Molecular criteria for the presence of precancerous pathology and cervical cancer may include a 3.10 [1.31; 3.28] fold increase in SAA values (U=41.0, p=0.02), 2.62 [2.79; 3.50] fold (U=137.0, p=0.001) in ICAM-1, 5.20 [3.84; 12.37] fold (U=138.5, p=0.001) in VCAM-1 and 4.32 [2.07; 5.02] fold (U=109.0, p<0.001) in sCD27 in cervical epithelium compared to the control group data. The gene discussed is ICAM1; the disease is cervical carcinoma.